Education
About Us
Working with TipRanks
Follow Us
Kintor Pharmaceutical Ltd (HK:9939)
:9939
RESEARCH TOOLSreports
Total Valuation
Kintor Pharmaceutical Ltd has a market cap or net worth of HK$651.62M. The enterprise value is ―.
Market CapHK$651.62M
Enterprise Value―
Share Statistics
Kintor Pharmaceutical Ltd has 447,499,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding447,499,600
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Kintor Pharmaceutical Ltd’s return on equity (ROE) is -0.53 and return on invested capital (ROIC) is -31.33%.
Return on Equity (ROE)-0.53
Return on Assets (ROA)-0.30
Return on Invested Capital (ROIC)-31.33%
Return on Capital Employed (ROCE)-0.41
Revenue Per Employee29.76K
Profits Per Employee-924.36K
Employee Count168
Asset Turnover<0.01
Inventory Turnover4.39
Valuation Ratios
The current PE Ratio of Kintor Pharmaceutical Ltd is -2.53. Kintor Pharmaceutical Ltd’s PEG ratio is 0.00.
PE Ratio-2.53
PS Ratio0.00
PB Ratio0.00
Price to Fair Value1.33
Price to FCF0.00
Price to Operating Cash Flow0.00
PEG Ratio0.00
Income Statement
In the last 12 months, Kintor Pharmaceutical Ltd had revenue of 5.00M and earned -155.29M in profits. Earnings per share was -0.36.
Revenue5.00M
Gross Profit-4.73M
Operating Income-144.57M
Pretax Income-155.27M
Net Income-155.29M
EBITDA-136.33M
Earnings Per Share (EPS)-0.36
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Kintor Pharmaceutical Ltd pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.49
52-Week Price Change44.44%
50-Day Moving Average1.35
200-Day Moving Average1.14
Relative Strength Index (RSI)54.88
Average Volume (3m)3.59M
Important Dates
Kintor Pharmaceutical Ltd upcoming earnings date is Sep 1, 2025, TBA (Confirmed).
Last Earnings DateMar 26, 2025
Next Earnings DateSep 1, 2025
Ex-Dividend Date―
Financial Position
Kintor Pharmaceutical Ltd as a current ratio of 1.03, with Debt / Equity ratio of 45.23%
Current Ratio1.03
Quick Ratio1.02
Debt to Market Cap0.34
Net Debt to EBITDA0.11
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Kintor Pharmaceutical Ltd has paid 18.00K in taxes.
Income Tax18.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Kintor Pharmaceutical Ltd EV to EBITDA ratio is -2.77, with an EV/FCF ratio of -1.90.
EV to Sales75.60
EV to EBITDA-2.77
EV to Free Cash Flow-1.90
EV to Operating Cash Flow-1.90
Balance Sheet
Kintor Pharmaceutical Ltd has HK$148.69M in cash and marketable securities with ¥133.01M in debt, giving a net cash position of -HK$15.68M billion.
Cash & Marketable SecuritiesHK$148.69M
Total Debt¥133.01M
Net Cash-HK$15.68M
Net Cash Per Share-HK$0.04
Tangible Book Value Per ShareHK$0.34
Margins
Gross margin is 0.00%, with operating margin of -2891.36%, and net profit margin of -3105.84%.
Gross Margin0.00%
Operating Margin-2891.36%
Pretax Margin-3105.48%
Net Profit Margin-3105.84%
EBITDA Margin-2726.52%
EBIT Margin-2992.26%
Analyst Forecast
The average price target for Kintor Pharmaceutical Ltd is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast85.23%